Saturday , 13 April 2024
Home Health Bristol-Myers Jumps Most Since 2014 After Its Psoriasis Drug Won Regulator Approval – BNN Bloomberg
Health

Bristol-Myers Jumps Most Since 2014 After Its Psoriasis Drug Won Regulator Approval – BNN Bloomberg

(Bloomberg) -- Bristol-Myers Squibb Co. shares gained the most in eight years after the company's psoriasis drug won approval from US regulators, the latest step in a bid to diversify beyond blockbuster products such as Eliquis.

 

(Bloomberg) — Bristol-Myers Squibb Co. shares gained the most in…

Continue reading your article with a FrontPage News Subscription

Already a Subscriber? Sign In  

OR
VIEW SUBSCRIPTION OPTIONS
Support independent journalism by subscribing